Shan Ahmed Khan, Author at TechStock²

Teva Stock News on Dec. 24, 2025: TEVA Rallies on S&P Credit Upgrade, $40 Price Target Hike, and Fresh Pipeline Catalysts

Teva Pharmaceutical Industries Limited (NYSE: TEVA; TASE: TEVA) stock is finishing 2025 with unusual momentum for a company long labeled “just a generics maker.” On Dec. 24, 2025, TEVA is trading around the $31–$32 range after a sharp run-up over

24 December 2025

Financial News·Investing·Pharmaceuticals·Stock Market

Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute, Inc. (Nasdaq: RZLT) is still in the spotlight on December 24, 2025, after a brutal mid-December selloff tied to its pivotal clinical trial news—and a wave of follow-on analyst downgrades, price-target resets, and investor-law-firm investigations. As of the latest

24 December 2025

Biotech News·Company Analysis·Financial Forecasts·Investment Insights·Stock Market

Chick-fil-A Set to Return to Portland in Early 2026 at Former Strip Club Near Mall 205, as Christmas Eve Dining Hours Go Top of Mind

PORTLAND, Ore. — December 24, 2025. On a day when millions of Americans are asking the same practical question — “What’s open on Christmas Eve and Christmas Day?” — Portland is also buzzing about a very different kind of food-and-hours

24 December 2025

Stock Market

Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama is ending 2025 in the spotlight as investors weigh a familiar question with an unusually sharp edge: how much is too much to pay for a business that keeps delivering? On December 24, 2025, the discussion is unfolding against

24 December 2025

Earnings Reports·Financial Analysis·Investing·Retail Industry·Stock Market

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is in the spotlight on December 24, 2025 after a sharp selloff driven by a major regulatory development: the U.S. Food and Drug Administration recommended that Reviva run an additional Phase 3 trial for

24 December 2025

FDA News·Financial Forecasts·Investment Analysis·Pharmaceuticals·Stock Market

Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Dec. 24, 2025 — Regencell Bioscience Holdings Limited (NASDAQ: RGC) is having one of those “stock market is a strange animal” moments again: the share price is moving sharply on a story dominated less by traditional fundamentals and more by

24 December 2025

Biotechnology·Financial News·Investment Analysis·Market Forecasts·Stock Market

Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

Wall Street is heading into Christmas Eve trading (Wednesday, December 24, 2025) with a familiar holiday mix: thin liquidity, an early close, and outsized market attention on macro headlines after the S&P 500 finished Tuesday at a fresh record. U.S.

24 December 2025

Financial Analysis·Investments·Market News·Stock Market·U.S. Economy

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth Corporation (NASDAQ: CGC, TSX: WEED) is ending 2025 with something cannabis stocks haven’t seen in a while: sustained, headline-driven volatility — the kind that can lift prices fast, then yank them back down just as quickly. As of

24 December 2025

Business News·Cannabis Industry·Financial Forecasts·Investment Analysis·Stock Market

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics, Inc. (NASDAQ: INDP) is getting unusual attention heading into December 24, 2025, after a late-December SEC filing laid out a $6.0 million preferred-stock financing, a boardroom reshuffle, and a new co-CEO / chairman appointment—a mix that can ignite

24 December 2025

Biotechnology·Company News·Financial Analysis·Investment Strategies·Stock Market

NVIDIA Stock News Today (Dec 24, 2025): NVDA Eyes China H200 Shipments as Wall Street Lifts 2026 Forecasts

NVIDIA Corporation (NASDAQ: NVDA) is heading into Christmas Eve with a familiar mix of fuel and friction: a powerful AI demand narrative, a fresh policy twist on China chip exports, and the kind of valuation debate that never sleeps—even when

24 December 2025

Investment·NVIDIA·Stock Market·Tech News·Wall Street

Churchill Capital Corp X (CCCX) Stock News on Dec. 24, 2025: Infleqtion Quantum SPAC Deal, Latest Catalysts, and What Comes Next

Churchill Capital Corp X (NASDAQ: CCCX) is back on traders’ radar heading into Dec. 24, 2025, after a sharp move higher this week that market watchers have largely tied to headline-driven momentum around its planned merger partner, Infleqtion—a neutral-atom quantum

24 December 2025

Investment Insights·Market Analysis·Stock Market

Tilray Brands (TLRY) Stock News Today: Cannabis Rescheduling, Earnings Date, Reverse Split, and Analyst Forecasts (Dec. 24, 2025)

Tilray Brands, Inc. (NASDAQ: TLRY) has spent December doing what cannabis stocks do best: moving fast, arguing loudly with gravity, and reacting to headlines like they’re caffeine. As of Wednesday, December 24, 2025, TLRY is trading around $10.53. The reason

24 December 2025

Business News·Cannabis Industry·Company Earnings·Investment Analysis·Stock Market